CA3015150A1 - Biomarkers of traumatic brain injury - Google Patents
Biomarkers of traumatic brain injury Download PDFInfo
- Publication number
- CA3015150A1 CA3015150A1 CA3015150A CA3015150A CA3015150A1 CA 3015150 A1 CA3015150 A1 CA 3015150A1 CA 3015150 A CA3015150 A CA 3015150A CA 3015150 A CA3015150 A CA 3015150A CA 3015150 A1 CA3015150 A1 CA 3015150A1
- Authority
- CA
- Canada
- Prior art keywords
- mir
- tbi
- mirna
- hsa
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000030886 Traumatic Brain injury Diseases 0.000 title claims abstract description 154
- 230000009529 traumatic brain injury Effects 0.000 title claims abstract description 154
- 239000000090 biomarker Substances 0.000 title description 27
- 239000002679 microRNA Substances 0.000 claims abstract description 188
- 108091070501 miRNA Proteins 0.000 claims abstract description 136
- 238000000034 method Methods 0.000 claims abstract description 76
- 108091090987 miR-425 stem-loop Proteins 0.000 claims abstract description 59
- 108091082652 miR-425-1 stem-loop Proteins 0.000 claims abstract description 59
- 108091048131 miR-425-2 stem-loop Proteins 0.000 claims abstract description 59
- 108091058133 miR-502 stem-loop Proteins 0.000 claims abstract description 55
- 108091031484 miR-335 stem-loop Proteins 0.000 claims abstract description 51
- 108091041631 miR-21-1 stem-loop Proteins 0.000 claims abstract description 44
- 108091062762 miR-21 stem-loop Proteins 0.000 claims abstract description 43
- 108091044442 miR-21-2 stem-loop Proteins 0.000 claims abstract description 43
- 238000012544 monitoring process Methods 0.000 claims abstract description 24
- 238000011282 treatment Methods 0.000 claims abstract description 24
- 238000001514 detection method Methods 0.000 claims abstract description 22
- 239000012530 fluid Substances 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000000523 sample Substances 0.000 claims description 103
- 208000014674 injury Diseases 0.000 claims description 56
- 230000006378 damage Effects 0.000 claims description 44
- 208000027418 Wounds and injury Diseases 0.000 claims description 43
- -1 miR-let-7g Proteins 0.000 claims description 22
- 210000002966 serum Anatomy 0.000 claims description 17
- 108091028141 MiR-203 Proteins 0.000 claims description 16
- 108091028232 Mir-184 Proteins 0.000 claims description 16
- 108091070404 miR-27b stem-loop Proteins 0.000 claims description 16
- 108091030637 miR-301b stem-loop Proteins 0.000 claims description 16
- 108091039462 miR-301b-1 stem-loop Proteins 0.000 claims description 16
- 108091028786 miR-301b-2 stem-loop Proteins 0.000 claims description 16
- 108091041309 miR-505 stem-loop Proteins 0.000 claims description 16
- 108091052964 miR-654 stem-loop Proteins 0.000 claims description 16
- 108091026036 miR-655 stem-loop Proteins 0.000 claims description 16
- 239000000758 substrate Substances 0.000 claims description 16
- 230000003247 decreasing effect Effects 0.000 claims description 15
- 210000003296 saliva Anatomy 0.000 claims description 15
- 238000002560 therapeutic procedure Methods 0.000 claims description 15
- 108091062140 Mir-223 Proteins 0.000 claims description 14
- 108091054642 miR-194 stem-loop Proteins 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 12
- 239000008280 blood Substances 0.000 claims description 12
- 108091026495 miR-148b stem-loop Proteins 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 11
- 108091007774 MIR107 Proteins 0.000 claims description 9
- 108091008063 MIR618 Proteins 0.000 claims description 9
- 108091028080 MiR-132 Proteins 0.000 claims description 9
- 108091093142 MiR-144 Proteins 0.000 claims description 9
- 108091027766 Mir-143 Proteins 0.000 claims description 9
- 229910021389 graphene Inorganic materials 0.000 claims description 9
- 108091035155 miR-10a stem-loop Proteins 0.000 claims description 9
- 108091026375 miR-135b stem-loop Proteins 0.000 claims description 9
- 108091059172 miR-135b-1 stem-loop Proteins 0.000 claims description 9
- 108091064811 miR-135b-3 stem-loop Proteins 0.000 claims description 9
- 108091062895 miR-144 stem-loop Proteins 0.000 claims description 9
- 108091037426 miR-152 stem-loop Proteins 0.000 claims description 9
- 108091041042 miR-18 stem-loop Proteins 0.000 claims description 9
- 108091062221 miR-18a stem-loop Proteins 0.000 claims description 9
- 108091081505 miR-190 stem-loop Proteins 0.000 claims description 9
- 108091086834 miR-190-2 stem-loop Proteins 0.000 claims description 9
- 108091086416 miR-192 stem-loop Proteins 0.000 claims description 9
- 108091063348 miR-193 stem-loop Proteins 0.000 claims description 9
- 108091036762 miR-193a stem-loop Proteins 0.000 claims description 9
- 108091073055 miR-193a-1 stem-loop Proteins 0.000 claims description 9
- 108091040345 miR-193a-2 stem-loop Proteins 0.000 claims description 9
- 108091092012 miR-199b stem-loop Proteins 0.000 claims description 9
- 108091049679 miR-20a stem-loop Proteins 0.000 claims description 9
- 108091030817 miR-20a-1 stem-loop Proteins 0.000 claims description 9
- 108091086627 miR-20a-2 stem-loop Proteins 0.000 claims description 9
- 108091069790 miR-20a-3 stem-loop Proteins 0.000 claims description 9
- 108091039792 miR-20b stem-loop Proteins 0.000 claims description 9
- 108091074563 miR-301-1 stem-loop Proteins 0.000 claims description 9
- 108091034144 miR-301-2 stem-loop Proteins 0.000 claims description 9
- 108091043187 miR-30a stem-loop Proteins 0.000 claims description 9
- 108091029750 miR-30a-1 stem-loop Proteins 0.000 claims description 9
- 108091030035 miR-30a-2 stem-loop Proteins 0.000 claims description 9
- 108091091870 miR-30a-3 stem-loop Proteins 0.000 claims description 9
- 108091067477 miR-30a-4 stem-loop Proteins 0.000 claims description 9
- 108091046551 miR-324 stem-loop Proteins 0.000 claims description 9
- 108091042879 miR-326 stem-loop Proteins 0.000 claims description 9
- 108091088856 miR-345 stem-loop Proteins 0.000 claims description 9
- 108091068963 miR-361 stem-loop Proteins 0.000 claims description 9
- 108091030670 miR-365 stem-loop Proteins 0.000 claims description 9
- 108091036688 miR-365-3 stem-loop Proteins 0.000 claims description 9
- 108091044721 miR-422a stem-loop Proteins 0.000 claims description 9
- 108091059135 miR-429 stem-loop Proteins 0.000 claims description 9
- 108091073864 miR-520d stem-loop Proteins 0.000 claims description 9
- 108091033741 miR-579 stem-loop Proteins 0.000 claims description 9
- 108091024411 miR-590 stem-loop Proteins 0.000 claims description 9
- 108091054673 miR-618 stem-loop Proteins 0.000 claims description 9
- 108091069023 miR-624 stem-loop Proteins 0.000 claims description 9
- 108091056454 miR-625 stem-loop Proteins 0.000 claims description 9
- 108091049896 miR-629 stem-loop Proteins 0.000 claims description 9
- 108091026054 miR-642 stem-loop Proteins 0.000 claims description 9
- 108091050734 miR-652 stem-loop Proteins 0.000 claims description 9
- 108091092761 miR-671 stem-loop Proteins 0.000 claims description 9
- 108091023525 miR-95 stem-loop Proteins 0.000 claims description 9
- 108091076732 miR-99a stem-loop Proteins 0.000 claims description 9
- 108091064318 miR-99a-1 stem-loop Proteins 0.000 claims description 9
- 108091086202 miR-99a-2 stem-loop Proteins 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 108091069047 Homo sapiens let-7i stem-loop Proteins 0.000 claims description 8
- 108091079658 miR-142-1 stem-loop Proteins 0.000 claims description 8
- 108091071830 miR-142-2 stem-loop Proteins 0.000 claims description 8
- 108091027034 miR-148a stem-loop Proteins 0.000 claims description 8
- 108091031326 miR-15b stem-loop Proteins 0.000 claims description 8
- 108091027943 miR-16 stem-loop Proteins 0.000 claims description 8
- 108091074057 miR-16-1 stem-loop Proteins 0.000 claims description 8
- 108091056204 miR-16-2 stem-loop Proteins 0.000 claims description 8
- 108091049641 miR-181-1 stem-loop Proteins 0.000 claims description 8
- 108091053227 miR-181a-1 stem-loop Proteins 0.000 claims description 8
- 108091092591 miR-181a-2 stem-loop Proteins 0.000 claims description 8
- 108091085286 miR-181a-3 stem-loop Proteins 0.000 claims description 8
- 108091061917 miR-221 stem-loop Proteins 0.000 claims description 8
- 108091047189 miR-29c stem-loop Proteins 0.000 claims description 8
- 108091079151 miR-29c-1 stem-loop Proteins 0.000 claims description 8
- 108091030938 miR-424 stem-loop Proteins 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 108091069085 Homo sapiens miR-126 stem-loop Proteins 0.000 claims description 7
- 108091092825 miR-24 stem-loop Proteins 0.000 claims description 7
- 108091048857 miR-24-1 stem-loop Proteins 0.000 claims description 7
- 108091047483 miR-24-2 stem-loop Proteins 0.000 claims description 7
- 108091027986 miR-27b-1 stem-loop Proteins 0.000 claims description 7
- 108091032408 miR-27b-2 stem-loop Proteins 0.000 claims description 7
- 108091088477 miR-29a stem-loop Proteins 0.000 claims description 7
- 210000002381 plasma Anatomy 0.000 claims description 7
- 108091070511 Homo sapiens let-7c stem-loop Proteins 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000000295 complement effect Effects 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 108091028066 Mir-126 Proteins 0.000 claims description 4
- 108091073704 let-7c stem-loop Proteins 0.000 claims description 4
- 108091081439 let-7c-1 stem-loop Proteins 0.000 claims description 4
- 108091062190 let-7c-2 stem-loop Proteins 0.000 claims description 4
- 108091064407 let-7c-3 stem-loop Proteins 0.000 claims description 4
- 108091042844 let-7i stem-loop Proteins 0.000 claims description 4
- 108091043251 let-7i-1 stem-loop Proteins 0.000 claims description 4
- 108091078001 let-7i-2 stem-loop Proteins 0.000 claims description 4
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 230000001631 hypertensive effect Effects 0.000 claims description 3
- 239000004090 neuroprotective agent Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229910002804 graphite Inorganic materials 0.000 claims description 2
- 239000010439 graphite Substances 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 239000000932 sedative agent Substances 0.000 claims 1
- 230000001624 sedative effect Effects 0.000 claims 1
- 108700011259 MicroRNAs Proteins 0.000 description 65
- 230000014509 gene expression Effects 0.000 description 26
- 239000000091 biomarker candidate Substances 0.000 description 16
- 238000003745 diagnosis Methods 0.000 description 13
- 230000008733 trauma Effects 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000011084 recovery Methods 0.000 description 11
- 238000009015 Human TaqMan MicroRNA Assay kit Methods 0.000 description 9
- 108091008065 MIR21 Proteins 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000011529 RT qPCR Methods 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000003752 polymerase chain reaction Methods 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 5
- 238000002591 computed tomography Methods 0.000 description 5
- 230000009514 concussion Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 108091091696 miR-331 stem-loop Proteins 0.000 description 5
- 230000009525 mild injury Effects 0.000 description 5
- 206010010071 Coma Diseases 0.000 description 4
- 206010019196 Head injury Diseases 0.000 description 4
- 108091067572 Homo sapiens miR-221 stem-loop Proteins 0.000 description 4
- 108091069527 Homo sapiens miR-223 stem-loop Proteins 0.000 description 4
- 108091069018 Homo sapiens miR-27b stem-loop Proteins 0.000 description 4
- 108091032108 Homo sapiens miR-424 stem-loop Proteins 0.000 description 4
- 108091007424 MIR27B Proteins 0.000 description 4
- 238000013103 analytical ultracentrifugation Methods 0.000 description 4
- 208000029028 brain injury Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000002247 constant time method Methods 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 230000003827 upregulation Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 230000001755 vocal effect Effects 0.000 description 4
- 108091067654 Homo sapiens miR-148a stem-loop Proteins 0.000 description 3
- 108091069045 Homo sapiens miR-15b stem-loop Proteins 0.000 description 3
- 108091070491 Homo sapiens miR-16-1 stem-loop Proteins 0.000 description 3
- 108091068927 Homo sapiens miR-16-2 stem-loop Proteins 0.000 description 3
- 108091067469 Homo sapiens miR-181a-1 stem-loop Proteins 0.000 description 3
- 108091067618 Homo sapiens miR-181a-2 stem-loop Proteins 0.000 description 3
- 108091070493 Homo sapiens miR-21 stem-loop Proteins 0.000 description 3
- 108091070373 Homo sapiens miR-24-1 stem-loop Proteins 0.000 description 3
- 108091070374 Homo sapiens miR-24-2 stem-loop Proteins 0.000 description 3
- 108091070398 Homo sapiens miR-29a stem-loop Proteins 0.000 description 3
- 108091065168 Homo sapiens miR-29c stem-loop Proteins 0.000 description 3
- 108091061616 Homo sapiens miR-652 stem-loop Proteins 0.000 description 3
- 108091070375 Homo sapiens miR-95 stem-loop Proteins 0.000 description 3
- 238000010162 Tukey test Methods 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 230000001149 cognitive effect Effects 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 238000013480 data collection Methods 0.000 description 3
- 239000012954 diazonium Substances 0.000 description 3
- 230000003828 downregulation Effects 0.000 description 3
- 238000013399 early diagnosis Methods 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 108091035591 miR-23a stem-loop Proteins 0.000 description 3
- 108091045911 miR-23a-1 stem-loop Proteins 0.000 description 3
- 108091047979 miR-23a-2 stem-loop Proteins 0.000 description 3
- 108091032054 miR-23a-3 stem-loop Proteins 0.000 description 3
- 108091029166 miR-23a-4 stem-loop Proteins 0.000 description 3
- 230000000926 neurological effect Effects 0.000 description 3
- 230000000324 neuroprotective effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 108091068928 Homo sapiens miR-107 stem-loop Proteins 0.000 description 2
- 108091069024 Homo sapiens miR-132 stem-loop Proteins 0.000 description 2
- 108091066895 Homo sapiens miR-135b stem-loop Proteins 0.000 description 2
- 108091068993 Homo sapiens miR-142 stem-loop Proteins 0.000 description 2
- 108091068992 Homo sapiens miR-143 stem-loop Proteins 0.000 description 2
- 108091068999 Homo sapiens miR-144 stem-loop Proteins 0.000 description 2
- 108091067009 Homo sapiens miR-148b stem-loop Proteins 0.000 description 2
- 108091068997 Homo sapiens miR-152 stem-loop Proteins 0.000 description 2
- 108091067995 Homo sapiens miR-192 stem-loop Proteins 0.000 description 2
- 108091067484 Homo sapiens miR-199b stem-loop Proteins 0.000 description 2
- 108091070496 Homo sapiens miR-20a stem-loop Proteins 0.000 description 2
- 108091032024 Homo sapiens miR-20b stem-loop Proteins 0.000 description 2
- 108091070365 Homo sapiens miR-30a stem-loop Proteins 0.000 description 2
- 108091067007 Homo sapiens miR-324 stem-loop Proteins 0.000 description 2
- 108091066896 Homo sapiens miR-331 stem-loop Proteins 0.000 description 2
- 108091066985 Homo sapiens miR-335 stem-loop Proteins 0.000 description 2
- 108091066987 Homo sapiens miR-345 stem-loop Proteins 0.000 description 2
- 108091067258 Homo sapiens miR-361 stem-loop Proteins 0.000 description 2
- 108091064509 Homo sapiens miR-502 stem-loop Proteins 0.000 description 2
- 108091064365 Homo sapiens miR-505 stem-loop Proteins 0.000 description 2
- 108091063718 Homo sapiens miR-579 stem-loop Proteins 0.000 description 2
- 108091061594 Homo sapiens miR-590 stem-loop Proteins 0.000 description 2
- 108091061649 Homo sapiens miR-625 stem-loop Proteins 0.000 description 2
- 108091061631 Homo sapiens miR-629 stem-loop Proteins 0.000 description 2
- 108091061680 Homo sapiens miR-655 stem-loop Proteins 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- 208000028361 Penetrating Head injury Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 208000028979 Skull fracture Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000007481 next generation sequencing Methods 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 206010052346 Brain contusion Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000007821 HATU Substances 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108091069046 Homo sapiens let-7g stem-loop Proteins 0.000 description 1
- 108091069022 Homo sapiens miR-130a stem-loop Proteins 0.000 description 1
- 108091068958 Homo sapiens miR-184 stem-loop Proteins 0.000 description 1
- 108091070490 Homo sapiens miR-18a stem-loop Proteins 0.000 description 1
- 108091069031 Homo sapiens miR-190a stem-loop Proteins 0.000 description 1
- 108091069034 Homo sapiens miR-193a stem-loop Proteins 0.000 description 1
- 108091068957 Homo sapiens miR-194-1 stem-loop Proteins 0.000 description 1
- 108091065167 Homo sapiens miR-194-2 stem-loop Proteins 0.000 description 1
- 108091067483 Homo sapiens miR-203a stem-loop Proteins 0.000 description 1
- 108091070492 Homo sapiens miR-23a stem-loop Proteins 0.000 description 1
- 108091065454 Homo sapiens miR-301a stem-loop Proteins 0.000 description 1
- 108091086474 Homo sapiens miR-301b stem-loop Proteins 0.000 description 1
- 108091067011 Homo sapiens miR-326 stem-loop Proteins 0.000 description 1
- 108091066899 Homo sapiens miR-340 stem-loop Proteins 0.000 description 1
- 108091067260 Homo sapiens miR-365a stem-loop Proteins 0.000 description 1
- 108091032093 Homo sapiens miR-422a stem-loop Proteins 0.000 description 1
- 108091032103 Homo sapiens miR-425 stem-loop Proteins 0.000 description 1
- 108091032930 Homo sapiens miR-429 stem-loop Proteins 0.000 description 1
- 108091064446 Homo sapiens miR-520d stem-loop Proteins 0.000 description 1
- 108091061645 Homo sapiens miR-618 stem-loop Proteins 0.000 description 1
- 108091061644 Homo sapiens miR-624 stem-loop Proteins 0.000 description 1
- 108091061629 Homo sapiens miR-642a stem-loop Proteins 0.000 description 1
- 108091061677 Homo sapiens miR-654 stem-loop Proteins 0.000 description 1
- 108091060463 Homo sapiens miR-671 stem-loop Proteins 0.000 description 1
- 108091068854 Homo sapiens miR-99a stem-loop Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091030146 MiRBase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 208000022214 Post-traumatic amnestic disease Diseases 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 208000002667 Subdural Hematoma Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003040 circulating cell Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- WVRIJHGUJNXDRZ-UHFFFAOYSA-N ethane-1,1-diamine Chemical group CC(N)N WVRIJHGUJNXDRZ-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108091008057 miR-10 Proteins 0.000 description 1
- 238000003253 miRNA assay Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000002610 neuroimaging Methods 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1603967.9 | 2016-03-08 | ||
| GBGB1603967.9A GB201603967D0 (en) | 2016-03-08 | 2016-03-08 | Biomarkers of traumatic brain injury |
| PCT/GB2017/050231 WO2017153710A1 (en) | 2016-03-08 | 2017-01-30 | Biomarkers of traumatic brain injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3015150A1 true CA3015150A1 (en) | 2017-09-14 |
Family
ID=55859162
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3015150A Pending CA3015150A1 (en) | 2016-03-08 | 2017-01-30 | Biomarkers of traumatic brain injury |
| CA3050996A Pending CA3050996A1 (en) | 2016-03-08 | 2017-12-22 | Biomarkers of traumatic brain injury |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3050996A Pending CA3050996A1 (en) | 2016-03-08 | 2017-12-22 | Biomarkers of traumatic brain injury |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US20190085395A1 (enExample) |
| EP (7) | EP3426796B1 (enExample) |
| JP (5) | JP7111619B2 (enExample) |
| KR (4) | KR20240167935A (enExample) |
| CN (4) | CN116004796A (enExample) |
| AU (3) | AU2017231845B2 (enExample) |
| CA (2) | CA3015150A1 (enExample) |
| ES (4) | ES2967073T3 (enExample) |
| GB (1) | GB201603967D0 (enExample) |
| NZ (1) | NZ782016A (enExample) |
| PL (2) | PL3712277T3 (enExample) |
| UA (1) | UA127918C2 (enExample) |
| WO (2) | WO2017153710A1 (enExample) |
| ZA (1) | ZA201805982B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3122905B1 (en) | 2014-03-27 | 2020-09-09 | Yale University | Circulating micrornas as biomarkers for endometriosis |
| GB201603967D0 (en) | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
| MX2019002425A (es) * | 2016-08-30 | 2019-08-16 | Univ Yale | Micro ácidos ribonucleicos como biomarcadores para la endometriosis. |
| WO2018175941A1 (en) * | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Analysis and prediction of traumatic brain injury and concusion symptoms |
| US11739323B2 (en) * | 2017-06-08 | 2023-08-29 | Temple University-Of The Commonwealth System Of Higher Education | Micro-RNAs as biomarkers for subconcussive and concussive injury and therapeutic applications |
| EP3803416A4 (en) * | 2018-05-31 | 2022-05-18 | Amydis, Inc. | COMPOSITIONS AND METHODS FOR DETECTING BRAIN TRAUMA |
| SG10201807529VA (en) * | 2018-09-03 | 2020-04-29 | Nec Asia Pacific Pte Ltd | Systems and methods for predicting recovery of a patient |
| US11315660B2 (en) | 2018-10-31 | 2022-04-26 | Dot Laboratories, Inc. | Method of detecting and treating endometriosis in a female subject |
| PE20220877A1 (es) * | 2019-02-14 | 2022-05-27 | Marker Diagnostics Uk Ltd | Biomarcadores salivales de lesion cerebral |
| KR102184840B1 (ko) * | 2019-05-20 | 2020-11-30 | 이화여자대학교 산학협력단 | 외상 후 스트레스 장애 진단 또는 예측용 바이오마커 및 그의 용도 |
| US11965879B2 (en) * | 2019-08-23 | 2024-04-23 | Mcmaster University | Method for diagnosing and assessing endometriosis |
| KR102272915B1 (ko) | 2019-09-27 | 2021-07-06 | 주식회사 이지다이아텍 | 새로운 외상성 뇌손상 및 감염병 poct 진단시스템 |
| CN110684835A (zh) * | 2019-10-12 | 2020-01-14 | 山东大学齐鲁医院 | miR-21在诊治蛛网膜下腔出血中的应用 |
| CN111419866A (zh) * | 2020-03-02 | 2020-07-17 | 南通大学 | miR-29a-3p在制备治疗周围神经损伤药物中的应用 |
| US12157918B2 (en) * | 2020-09-04 | 2024-12-03 | University Of Kentucky Research Foundation | Clinical assessment of cerebral vasospasm risk following aneurysmal subarachnoid hemorrhage |
| IL307369A (en) | 2021-04-02 | 2023-11-01 | Marker Holdings Ag | Biomarkers of muscle and skeletal injury |
| CN116219019A (zh) * | 2023-03-02 | 2023-06-06 | 圣湘生物科技股份有限公司 | 一种用于结直肠癌诊断的microRNA标志物组合物及检测试剂、检测试剂盒 |
| WO2024242411A1 (ko) | 2023-05-19 | 2024-11-28 | 주식회사 이지다이아텍 | 자동 항체 커플링 및 이를 확인하는 장치 |
| WO2025039033A1 (en) * | 2023-08-21 | 2025-02-27 | Glia Diagnostics Pty Ltd | Methods and reagents for diagnosis and/or prognosis of traumatic brain injury |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH31414A (en) | 1994-02-24 | 1998-10-29 | Boehringer Ingelheim Int | Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples. |
| WO1999033018A1 (de) | 1997-12-18 | 1999-07-01 | Infineon Technologies Ag | Vorrichtung zur bilderfassung |
| RU66524U1 (ru) | 2007-05-03 | 2007-09-10 | Федор Андреевич Егоров | Сооружение, в котором обеспечена возможность комплексного мониторинга сооружения |
| CN101424640B (zh) | 2007-11-02 | 2012-07-25 | 江苏命码生物科技有限公司 | 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法 |
| DE102008017652A1 (de) | 2008-04-04 | 2009-10-08 | Leonhard Kurz Stiftung & Co. Kg | Sicherheitselement sowie Verfahren zur Herstellung eines Sicherheitselements |
| EP2336353A1 (en) | 2009-12-17 | 2011-06-22 | febit holding GmbH | miRNA fingerprints in the diagnosis of diseases |
| HUE040281T2 (hu) * | 2009-09-14 | 2019-03-28 | Banyan Biomarkers Inc | Autoantitest markerek traumás agysérülés diagnózisára |
| RU93660U1 (ru) | 2010-02-08 | 2010-05-10 | Государственное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО "РостГМУ Росздрава") | Тест-полоска для диагностики нефропатии |
| CN103237901B (zh) * | 2010-03-01 | 2016-08-03 | 卡里斯生命科学瑞士控股有限责任公司 | 用于治疗诊断的生物标志物 |
| WO2013159091A2 (en) * | 2012-04-20 | 2013-10-24 | Aptamir Therapeutics, Inc. | Mirna modulators of thermogenesis |
| US20150203916A1 (en) | 2012-06-27 | 2015-07-23 | Music Foundation For Research Development | Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm |
| GB201223243D0 (en) * | 2012-12-21 | 2013-02-06 | King S College London | Detection method |
| EP3418430B1 (en) | 2013-03-15 | 2023-03-29 | The Trustees of the University of Pennsylvania | Blood biomarkers that predict persistent cognitive dysfunction after concussion |
| US9890428B2 (en) * | 2013-05-14 | 2018-02-13 | Ohio State Innovation Foundation | MiRNA biomarkers for radiation biodosimetry |
| US9434945B2 (en) * | 2013-08-02 | 2016-09-06 | University Of Maryland, Baltimore | Use of miR-23a-3p and/or miR-27a-3p mimics as therapeutic agents for inhibition of neuronal apoptosis following brain injury |
| CN103667445A (zh) * | 2013-10-16 | 2014-03-26 | 石磊 | 一种脑梗塞早期诊断标志物及其应用 |
| WO2015073972A1 (en) * | 2013-11-18 | 2015-05-21 | Diamir, Llc | METHODS OF USING mIRNAs FROM BODILY FLUIDS FOR DETECTION AND MONITORING OF PARKINSON'S DISEASE (PD) |
| WO2015128192A1 (en) * | 2014-02-26 | 2015-09-03 | Koninklijke Philips N.V. | Light reflectance based detection |
| WO2015134551A1 (en) * | 2014-03-03 | 2015-09-11 | Banyan Biomarkers, Inc. | Micro rna markers for diagnosis of a neurological condition |
| US9605315B2 (en) * | 2014-03-26 | 2017-03-28 | The University Of Montana | Detection of traumatic brain injury |
| WO2015153864A2 (en) | 2014-04-02 | 2015-10-08 | Hopkins Patricia T | Methods for treating inflammatory conditions |
| WO2015164431A2 (en) * | 2014-04-22 | 2015-10-29 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Methods, processes, devices and kits for the measurement of post traumatic stress disorder microrna markers |
| WO2015196191A1 (en) * | 2014-06-20 | 2015-12-23 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Microrna biomarkers for traumatic brain injury and methods of use thereof |
| ES2558262B2 (es) | 2014-08-01 | 2016-07-14 | Universidad Católica De Valencia "San Vicente Mártir" | Método de diagnóstico de fibromialgia basado en microRNAs |
| CN104293791B (zh) * | 2014-10-22 | 2018-01-12 | 首都医科大学附属北京友谊医院 | miR‑200b在制备Rac‑1蛋白表达抑制剂中的新用途 |
| CA2993989A1 (en) * | 2015-07-29 | 2017-02-02 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Microrna biomarkers for traumatic brain injury and methods of use thereof |
| WO2017044650A1 (en) | 2015-09-08 | 2017-03-16 | The Translational Genomics Research Institute | Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries |
| GB201603967D0 (en) | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
| WO2018175941A1 (en) | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Analysis and prediction of traumatic brain injury and concusion symptoms |
| WO2018175422A1 (en) | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Method for diagnosing or monitoring conditions characterized by abnormal temporal variations method of normalizing epigenetic data to compensate for temporal variations |
| PE20220877A1 (es) | 2019-02-14 | 2022-05-27 | Marker Diagnostics Uk Ltd | Biomarcadores salivales de lesion cerebral |
-
2016
- 2016-03-08 GB GBGB1603967.9A patent/GB201603967D0/en not_active Ceased
-
2017
- 2017-01-30 US US16/083,178 patent/US20190085395A1/en not_active Abandoned
- 2017-01-30 UA UAA201809265A patent/UA127918C2/uk unknown
- 2017-01-30 KR KR1020247037409A patent/KR20240167935A/ko active Pending
- 2017-01-30 PL PL20169635.8T patent/PL3712277T3/pl unknown
- 2017-01-30 EP EP17703217.4A patent/EP3426796B1/en active Active
- 2017-01-30 CN CN202211408247.8A patent/CN116004796A/zh active Pending
- 2017-01-30 ES ES17703217T patent/ES2967073T3/es active Active
- 2017-01-30 AU AU2017231845A patent/AU2017231845B2/en active Active
- 2017-01-30 JP JP2018546868A patent/JP7111619B2/ja active Active
- 2017-01-30 CN CN201780015193.XA patent/CN109415769B/zh active Active
- 2017-01-30 EP EP20169635.8A patent/EP3712277B1/en active Active
- 2017-01-30 ES ES20169635T patent/ES2987237T3/es active Active
- 2017-01-30 WO PCT/GB2017/050231 patent/WO2017153710A1/en not_active Ceased
- 2017-01-30 KR KR1020187026295A patent/KR102729795B1/ko active Active
- 2017-01-30 CA CA3015150A patent/CA3015150A1/en active Pending
- 2017-01-30 EP EP24174972.0A patent/EP4403649A3/en active Pending
- 2017-01-30 NZ NZ782016A patent/NZ782016A/en unknown
- 2017-12-22 EP EP17822770.8A patent/EP3574117B1/en active Active
- 2017-12-22 EP EP25164531.3A patent/EP4582559A3/en active Pending
- 2017-12-22 JP JP2019539924A patent/JP7132224B2/ja active Active
- 2017-12-22 WO PCT/GB2017/053887 patent/WO2018138468A1/en not_active Ceased
- 2017-12-22 ES ES20169652T patent/ES2965297T3/es active Active
- 2017-12-22 CA CA3050996A patent/CA3050996A1/en active Pending
- 2017-12-22 CN CN201780084939.2A patent/CN110291210B/zh not_active Expired - Fee Related
- 2017-12-22 ES ES23184544T patent/ES3032995T3/es active Active
- 2017-12-22 EP EP20169652.3A patent/EP3712280B8/en active Active
- 2017-12-22 PL PL23184544.7T patent/PL4257705T3/pl unknown
- 2017-12-22 EP EP23184544.7A patent/EP4257705B1/en active Active
- 2017-12-22 US US15/852,128 patent/US10563262B2/en active Active
- 2017-12-22 KR KR1020197022615A patent/KR102618993B1/ko active Active
- 2017-12-22 KR KR1020237044544A patent/KR20240011189A/ko active Pending
- 2017-12-22 CN CN202410665501.5A patent/CN118441040A/zh active Pending
-
2018
- 2018-09-06 ZA ZA2018/05982A patent/ZA201805982B/en unknown
-
2019
- 2019-12-31 US US16/732,254 patent/US11414705B2/en active Active
-
2022
- 2022-07-21 JP JP2022116002A patent/JP7413455B2/ja active Active
- 2022-07-28 US US17/876,472 patent/US12467095B2/en active Active
- 2022-09-08 US US17/940,988 patent/US20230313300A1/en active Pending
-
2023
- 2023-12-13 AU AU2023282212A patent/AU2023282212B2/en active Active
- 2023-12-27 JP JP2023220147A patent/JP7654769B2/ja active Active
-
2025
- 2025-03-19 JP JP2025044721A patent/JP2025098112A/ja active Pending
- 2025-11-05 AU AU2025263788A patent/AU2025263788A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230313300A1 (en) | Biomarkers of traumatic brain injury | |
| HK40095431A (en) | Biomarkers of traumatic brain injury | |
| RU2771757C2 (ru) | Биомаркеры травматического повреждения головного мозга | |
| HK40114018A (en) | Biomarkers of traumatic brain injury | |
| HK40034626A (en) | Biomarkers of severe traumatic brain injury | |
| HK40034626B (en) | Biomarkers of severe traumatic brain injury | |
| OA19460A (en) | Biomarkers of traumatic brain injury. | |
| HK1258615B (en) | Biomarkers of traumatic brain injury | |
| HK40011329B (en) | Biomarkers of traumatic brain injury | |
| HK40011329A (en) | Biomarkers of traumatic brain injury | |
| BR112018067882B1 (pt) | Método in vitro para diagnosticar e/ou monitorar tbi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220128 |
|
| EEER | Examination request |
Effective date: 20220128 |
|
| EEER | Examination request |
Effective date: 20220128 |
|
| EEER | Examination request |
Effective date: 20220128 |
|
| EEER | Examination request |
Effective date: 20220128 |
|
| EEER | Examination request |
Effective date: 20220128 |